日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessing favipiravir impact on SARS-CoV-2 transmission within households: Insights from a multi-center study (FaviPrev)

评估法匹拉韦对家庭内 SARS-CoV-2 传播的影响:一项多中心研究的启示 (FaviPrev)

Siripongboonsitti, Taweegrit; Muadchimkaew, Marisa; Tawinprai, Kriangkrai; Issaranon, Ornisa; Meepholkij, Wichuda; Arttawejkul, Pureepat; Vararungzarit, Apiradee; Dhissayakamol, Onwalee; Preeyachit, Wilaiporn; Soonklang, Kamonwan; Mahanonda, Nithi

Favipiravir treatment in non-severe COVID-19: promising results from multicenter propensity score-matched study (FAVICOV)

法匹拉韦治疗非重症 COVID-19:多中心倾向评分匹配研究 (FAVICOV) 的有希望的结果

Siripongboonsitti, Taweegrit; Muadchimkaew, Marisa; Tawinprai, Kriangkrai; Issaranon, Ornisa; Meepholkij, Wichuda; Arttawejkul, Pureepat; Vararungzarit, Apiradee; Thavornwattana, Kaewklao; Mahanonda, Nithi